Fundraising Fox

TIXiMED

Birmingham, US · Founded 2021 · Delaware corporation

Biotech

Founders & leadership

TM
Thomas Michael Goodrich IIExecutive

Board

AS
Aneth ShalevBoard director

Reported raises · per SEC filings

Form D private placements

$550K disclosed across 1 of 2 rounds · 2024–2026

▶$550KraisedNov 2024 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas Michael Goodrich IIExecutive Officer, Director
  • Aneth ShalevDirector
Offering amount
$550K
Amount sold
$550K
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Pharma veteran relocates to Birmingham to lead biotech's $35M funding round - Birmingham Business Journalbizjournals.com · May 2026TIXiMED Announces Expansion of Program-Related Investment from the Helmsley Charitable Trustbusinesswire.com · Mar 2026Trusted Partners and Investors - TIXiMEDtiximed.com · Feb 2025Tiximed Secures $2.65M Investment for Novel Oral Therapy Trialsclinicaltrialvanguard.com · Dec 2024TIXiMED Announces a $2.65M Program-Related Investment from the Helmsley Charitable Trust to Initiate Clinical Trials of Its Novel Oral Therapy for Beta Cell Survival and Functionbusinesswire.com · Dec 2024News - TIXiMEDtiximed.com · Dec 2022

Frequently asked questions

How much funding has TIXiMED raised?
TIXiMED has disclosed $550K raised across 1 of its 2 known rounds.
Where is TIXiMED headquartered?
TIXiMED is headquartered in Birmingham, US.